GSK

University of Cambridge / GSK: Human genetics can support the development of new therapies

An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated…

8 years ago

Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for GSK’s Nucala® as a treatment for bronchial asthma

LONDON, 29-Mar-2016 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE:GSK) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has…

8 years ago

Kuehne + Nagel to run the core business of transporting products from the raw materials supplier to trade customers for GlaxoSmithKline (GSK)

London / UK, Schindellegi / CH, 13-1-2016 — /EuropaWire/ — Kuehne + Nagel and GSK signed an end-to-end global logistics…

8 years ago

HIV-1: ViiV Healthcare formalised its collaboration with Janssen Sciences Ireland UC

LONDON, 11-1-2016 — /EuropaWire/ — ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as…

8 years ago

GSK further strengthens and expands its vaccines presence in US by establishing new global centre for vaccines R&D in Rockville, Maryland

New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint London and Philadelphia, 6-4-2015 — /EuropaWire/ — GSK…

9 years ago

GSK announces the winners of its second Discovery Fast Track Challenge

14 proposals selected from 428 entries in 26 countries Project areas include HIV, cancer and neurodegeneration LONDON, 4-12-2014 — /EuropaWire/…

9 years ago

GSK submits variation to the Marketing Authorisation for eltrombopag (Revolade™) to the European Medicines Agency (EMA)

LONDON, 13-11-2014 — /EuropaWire/ — GSK today announced the submission to the European Medicines Agency (EMA) of a variation to…

9 years ago

The European Medicines Agency gives scientific advice to GSK on its development plan for an Ebola vaccine

Developers encouraged to request accelerated procedure for scientific advice LONDON, 30-10-2014 — /EuropaWire/ — The European Medicines Agency (EMA) has…

10 years ago

GSK: Stiefel to start phase III study of subcutaneous ofatumumab in patients with rare autoimmune skin disorder pemphigus vulgaris

LONDON, 9-10-2014 — /EuropaWire/ — Stiefel, a GSK company, today announced the start of a phase III study to evaluate…

10 years ago

GSK presented data at European Respiratory Society Congress that show blood eosinophil levels may help inform COPD treatment decisions

LONDON, 10-9-2014 — /EuropaWire/ — GSK today presented data at the European Respiratory Society (ERS) Congress that show blood eosinophil…

10 years ago

GSK announces £5m collaboration with UK and South African Medical Research Councils to support research into non-communicable diseases in Africa

LONDON, 10-9-2014 — /EuropaWire/ — GSK today announced a £5m collaboration with the UK and South African Medical Research Councils,…

10 years ago

GlaxoSmithKline plc received FDA Breakthrough Therapy designation for its Tafinlar® (dabrafenib)

Marks GSK’s fourth Breakthrough Therapy designation London, UK, 17-1-2014 — /EuropaWire/ —  GlaxoSmithKline plc (LSE: GSK) announced today that the U.S.…

10 years ago

GlaxoSmithKline submitted NDA to US FDA for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler

London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US…

11 years ago

GSK and Pfizer owned ViiV Healthcare announced US regulatory submission for STR combining dolutegravir with abacavir and lamivudine for people living with HIV

London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its…

11 years ago

GSK President Europe, Japan, Emerging Markets & Asia Pacific Abbas Hussain issued statement on the meeting with Chinese Ministry of Public Security

22-7-2013 — /EuropaWire/ — Following a meeting with the Chinese Ministry of Public Security to discuss their investigation into GSK, Abbas Hussain,…

11 years ago
Show previous Posts